KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Capital Expenditures (2016 - 2025)

Medpace Holdings' Capital Expenditures history spans 11 years, with the latest figure at $4.5 million for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 40.65% year-over-year to $4.5 million; the TTM value through Dec 2025 reached $31.4 million, down 14.21%, while the annual FY2025 figure was $31.4 million, 14.21% down from the prior year.
  • Capital Expenditures reached $4.5 million in Q4 2025 per MEDP's latest filing, down from $10.7 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $12.9 million in Q2 2024 to a low of $4.5 million in Q4 2025.
  • Average Capital Expenditures over 5 years is $8.5 million, with a median of $8.9 million recorded in 2021.
  • Peak YoY movement for Capital Expenditures: surged 86.42% in 2022, then plummeted 52.51% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $9.1 million in 2021, then rose by 1.39% to $9.2 million in 2022, then increased by 8.04% to $10.0 million in 2023, then decreased by 23.46% to $7.6 million in 2024, then crashed by 40.65% to $4.5 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Capital Expenditures are $4.5 million (Q4 2025), $10.7 million (Q3 2025), and $6.1 million (Q2 2025).